EULAR did not distinguish the choice of calcineurin inhibitor or biologics based on renal histology class ... of targeted therapies investigating cancer (excluding non-melanoma skin cancer [NMSC]) and ...

Patients with BCC who used ADPs prior to surgery had a significantly greater risk of poor outcomes than those who did not use ADPs.

Researchers conducted a retrospective cohort study to assess the predictive value of molecular profiling on thyroid tumor behavior.

Dana-Farber research uncovered the potential for underdiagnosis of this aggressive cancer and identified additional tests ...